Minerva Surgical Inc at UBS Global Healthcare Conference Transcript
Good morning, everyone. Thank you for getting up bright and early for Day 3 of the UBS Healthcare Conference. I'm Seth Damergy, I'm a Managing Director and I cover medical devices for the bank, and I am pleased to introduce and sit with our next group that's going to present, which is Minerva Surgical. Known team for quite some time and with us today, we have Dave Clapper, CEO; and Joel Jung, CFO of the company.
Minerva, if you're unfamiliar with the company, it's a Nasdaq-listed company focused on Abnormal Uterine Bleeding. The company recently IPO-ed last year and I thought we'd go through some questions over the next 40 minutes. And I'm just going to lead in with them, so thank you again for joining us, gentlemen.
Thanks and welcome.
Thanks for having us.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |